ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2021 and some content may be unavailable. To unlock all content for 2021, please visit the archives.

Abstract: PO2524

Effect of Clinical Decision Support with Audit and Feedback for Prevention of AKI in Coronary Angiography and Intervention: Stepped Wedge Cluster Randomized Trial

Session Information

Category: Acute Kidney Injury

  • 102 AKI: Clinical, Outcomes, and Trials

Authors

  • James, Matthew T., University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada
  • Har, Bryan J., University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada
  • Tyrrell, Benjamin D., University of Alberta Faculty of Medicine & Dentistry, Edmonton, Alberta, Canada
  • Faris, Peter D., Alberta Health Services, Calgary, Alberta, Canada
  • Tan, Zhi, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada
  • Spertus, John, University of Missouri, Columbia, Missouri, United States
  • Wilton, Stephen B., University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada
  • Ghali, William A., University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada
  • Knudtson, Merril L., University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada
  • Pannu, Neesh I., University of Alberta Faculty of Medicine & Dentistry, Edmonton, Alberta, Canada
  • Klarenbach, Scott, University of Alberta Faculty of Medicine & Dentistry, Edmonton, Alberta, Canada
  • Graham, Michelle M., University of Alberta Faculty of Medicine & Dentistry, Edmonton, Alberta, Canada
Background

Contrast-associated acute kidney injury (CA-AKI) is a common complication of coronary angiography and percuateous coronary intervention (PCI). We evaluated whether the incidence of CA-AKI was reduced with an intervention including clinical decision support with audit and feedback.

Methods

In this cluster-randomized, stepped-wedge trial conducted in Alberta, Canada, we randomly assigned all invasive cardiologists to various start dates for an intervention that included education, point-of-care computerized clinical decision support on contrast volume and IV fluid targets, and repeated audit and feedback related to these processes for CA-AKI prevention. The eligible study population included adults ≥18 years of age, not receiving dialysis, with a predicted risk of CA-AKI >5%, who received non-emergency coronary angiography or PCI. The primary outcome was incidence of AKI based on the KDIGO serum creatinine criteria. Analyses were performed according to the intention-to-treat principle, using mixed-effect models to account for clustering in the data.

Results

Of 34 physicians randomized, 3 retired prior to randomization, and the remaining 31 received the intervention. There were 7,087 procedures performed in 6,449 eligible patients; mean (SD) age 70.2 (10.7) years, 2,292 (32.3%) female, mean (SD) eGFR 62.7 (22.4) mL/min/1.73m2. The proportion of procedures where the desired contrast volume limit was exceeded was reduced from 41.0% to 29.2% (p<0.01), while the proportion who received hemodynamically guided IV fluids increased from 35.3% to 42.0% (p<0.01) with the intervention. The incidence of CA-AKI was significantly reduced, from 9.2% (280 events / 3,036 procedures) before the intervention to 8.2% (334 events / 4,051 procedures) with the intervention (time adjusted odds ratio, 0.74; 95% CI, 0.58 to 0.94). There was no statistical evidence of effect modification by age, sex, comorbidity, or baseline CA-AKI risk.

Conclusion

An intervention combining education, clinical decision support, and audit and feedback resulted in less contrast dye use, greater intravenous fluid administration, and reduced the incidence of CA-AKI following coronary angiography and PCI.

Funding

  • Government Support - Non-U.S.